AI Article Synopsis

  • - The study investigates the relationship between surgical resection and cancer-specific mortality (CSM) in patients with soft tissue pelvic sarcomas, focusing on different histologic subtypes such as liposarcoma, leiomyosarcoma, and sarcoma NOS, using data from the SEER database.
  • - Analysis of 2,491 patients reveals that liposarcoma is the most prevalent subtype, with high surgical resection rates in non-metastatic cases (92% for liposarcoma), and those who had surgery showed lower CSM rates compared to those who did not.
  • - The findings indicate that surgical resection generally offers a protective benefit against CSM in non-metastatic patients across histologic sub

Article Abstract

: The impact of surgical resection versus non-resection on cancer-specific mortality (CSM) in soft tissue pelvic sarcoma remains largely unclear, particularly when considering histologic subtypes such as liposarcoma, leiomyosarcoma, and sarcoma NOS. The objective of the present study was to first report data regarding the association between surgical resection status and CSM in soft tissue pelvic sarcoma. : Using data from the Surveillance, Epidemiology, and End Results (SEER) database from 2000 to 2019, we identified 2491 patients diagnosed with pelvic soft tissue sarcoma. Cumulative incidence plots were used to illustrate CSM and other-cause mortality rates based on the histologic subtype and surgical resection status. Competing risk regression models were employed to assess whether surgical resection was an independent predictor of CSM in both non-metastatic and metastatic patients. : Among the 2491 patients with soft tissue pelvic sarcoma, liposarcoma was the most common subtype (41%), followed by leiomyosarcoma (39%) and sarcoma NOS (20%). Surgical resection rates were 92% for liposarcoma, 91% for leiomyosarcoma, and 58% for sarcoma NOS in non-metastatic patients, while for metastatic patients, the rates were 55%, 49%, and 23%, respectively. In non-metastatic patients who underwent surgical resection, five-year CSM rates by histologic subtype were 10% for liposarcoma, 32% for leiomyosarcoma, and 27% for sarcoma NOS. The multivariable competing risk regression analysis showed that surgical resection provided a protective effect across all histologic subtypes in non-metastatic patients (liposarcoma HR: 0.2, leiomyosarcoma HR: 0.5, sarcoma NOS HR: 0.4). In metastatic patients, surgical resection had a protective effect for those with leiomyosarcoma (HR: 0.6) but not for those with sarcoma NOS. An analysis for metastatic liposarcoma was not possible due to insufficient data. In non-metastatic soft tissue pelvic sarcoma, surgical resection may be linked to a reduction in CSM. However, in metastatic patients, this protective effect appears to be limited primarily to those with leiomyosarcoma.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11476817PMC
http://dx.doi.org/10.3390/jcm13195787DOI Listing

Publication Analysis

Top Keywords

surgical resection
40
soft tissue
24
tissue pelvic
16
pelvic sarcoma
16
metastatic patients
16
sarcoma
12
histologic subtype
12
leiomyosarcoma sarcoma
12
non-metastatic patients
12
surgical
10

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!